Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.010
-0.490 (-32.67%)
Jan 24, 2025, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $247.41 million as of January 29, 2025. Its market cap has decreased by -63.85% in one year.
Market Cap
247.41M
Enterprise Value
74.71M
Revenue
21.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.01
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 247.41M, a decrease of -54.05%. That is a compound annual growth rate of -16.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 29, 2025 | 247.41M | -23.84% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 2.04B |
SS Innovations International | 1.55B |
Veradigm | 1.36B |
Nika Pharmaceuticals | 1.02B |
Elite Pharmaceuticals | 494.65M |
Glass House Brands | 469.85M |
Northwest Biotherapeutics | 381.37M |
CytoDyn | 316.76M |